Johnson & Johnson vs ResMed Inc.
JNJ vs RMD — side-by-side comparison from reported financials. JNJ leads 5, RMD leads 5 of 10 comparable metrics.
Johnson & Johnson
JNJ · Healthcare
$261.79+2.07%Mixed
ResMed Inc.
RMD · Healthcare
$230.05+1.46%Mixed
| Metric | JNJ | RMD |
|---|---|---|
| Price | $261.79 | $230.05 |
| Market cap | $631B | $32.4B |
| Revenue (TTM) | $97.9B | $5.65B |
| Revenue growth | +5.6% | +10.2% |
| Net margin | 21.5% | 26.9% |
| Free cash flow | $22.2B | $1.65B |
| Net cash (debt) | ($27.8B) | $643M |
| 1-year price return | +37.0% | -17.2% |
| P/E | 29.9 | 21.2 |
| P/E vs own history (cheap-side %) | 16% | 91% |
| Dividend yield | 2.00% | 1.08% |
| Return on equity | 26% | 24% |
| CV checks passed | 10 of 11 | 10 of 11 |
| Employees | 140,800 | 11,370 |
Full résumé-style profiles: JNJ CV · RMD CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.